Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

BACKGROUND: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. METHODS: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is ass...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084355/
https://www.ncbi.nlm.nih.gov/pubmed/33933206
http://dx.doi.org/10.1016/S0140-6736(21)00676-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084355/
https://www.ncbi.nlm.nih.gov/pubmed/33933206
http://dx.doi.org/10.1016/S0140-6736(21)00676-0

Ejemplares similares